The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nasal vestibulitis: An MNCCTN natural history trial—Nasal vestibulitis symptoms associated with paclitaxel, docetaxel, and other chemotherapy agents.
 
Elizabeth Jane Cathcart-Rake
No Relationships to Disclose
 
David Zahrieh
No Relationships to Disclose
 
Deanne s. Smith
No Relationships to Disclose
 
Susan Young
No Relationships to Disclose
 
Eric G. Wolfe
No Relationships to Disclose
 
Amanda O'Connor
No Relationships to Disclose
 
Stephan Thome
No Relationships to Disclose
 
Mario E. Lacouture
Honoraria - ADC Therapeutics; Amgen; Apricity Health; AstraZeneca; azitra; azitra; Deciphera; Galderma; Genentech; Janssen; Johnson & Johnson; Kyowa Hakko Kirin; Loxo; Menlo Therapeutics; NCODA; Novartis; Novocure; OnQuality Pharmaceuticals; QED Therapeutics; Roche/Genentech; Seattle Genetics/Astellas; Teva; Teva
Consulting or Advisory Role - Abbvie; Adgero Biopharmaceuticals; Adjucare; Allergan; Amgen; Amryt Pharma; AstraZeneca; Bayer; Biotechspert; Boehringer Ingelheim; Celldex; Debiopharm Group; Dignitana; E.R. Squibb Sons, LLC; EMD Serono; Galderma; Genentech; Helsinn Healthcare; Janssen Research & Development; Johnson & Johnson; Legacy Healthcare Services; Legacy Healthcare Services; LEO Pharma; Lindi Skin; Lutris; Manner SAS; Menlo Therapeutics; Merck; Novartis; Novocure; OncoDerm; OnQuality Pharmaceuticals; OurBrainBank; Parexel; Paxman; Pierre Fabre; Roche; Roche; Roche; Roche; Seagen; Takeda/Millennium; Teva
Research Funding - Lutris; Novocure; Paxman; US Biotest; Veloce Pharmaceuticals
Travel, Accommodations, Expenses - AstraZeneca; Deciphera; Kyowa Hakko Kirin; Novocure; Teva
Other Relationship - OncoDerm (I)
(OPTIONAL) Uncompensated Relationships - OncoDerm; OncoDerm
 
Terra Register
No Relationships to Disclose
 
Jill Piens
No Relationships to Disclose
 
Shaylene McCue
No Relationships to Disclose
 
Charles L. Loprinzi
Consulting or Advisory Role - Asahi Kasei; Disarm Therapeutics; Metys Pharmaceuticals; Mitsubishi Tanabe Pharma; NKMax; OnQuality Pharmaceuticals; PledPharma
Research Funding - Bristol-Myers Squibb (Inst)
Other Relationship - Cynosure/Hologic